Diéguez G, Fernández N, García J L, García-Villalón A L, Monge L, Gomez B
Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, Madrid, Spain.
Eur J Pharmacol. 1997 Jul 9;330(2-3):185-93. doi: 10.1016/s0014-2999(97)00181-7.
This study was performed to examine the role of nitric oxide in the effects of hypoglycemia on the cerebral circulation. Hypoglycemia was induced with insulin and its effects on cerebral blood flow (measured with an electromagnetic flow transducer placed on the internal maxillary artery) were studied in awake goats under control conditions and after administration of the nitric oxide synthesis inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 47 mg/kg). Also, cerebrovascular reactivity to vasodilator stimuli was examined during insulin-induced severe hypoglycemia, before and after L-NAME treatment. In five animals under control conditions (glycemia = 90 +/- 7 mg/dl, cerebral blood flow = 64 +/- 4 ml/min, mean systemic arterial pressure = 102 +/- 4 mmHg, cerebrovascular resistance = 1.62 +/- 0.11 mmHg/ml per min and heart rate = 73 +/- 6 beats/min), insulin decreased glycemia: when hypoglycemia was moderate (glycemia = 46 +/- 2 mg/dl) or severe (glycemia = 26 +/- 1 mg/dl) cerebral blood flow increased by 25 +/- 4% and 47 +/- 6%, and cerebrovascular resistance decreased by 18 +/- 3% and 34 +/- 4%, respectively. Under basal conditions, L-NAME did not affect glycemia but reduced resting cerebral blood flow by 37 +/- 2%, increased mean arterial pressure by 33 +/- 2% and decreased heart rate by 28 +/- 3%; after L-NAME, both moderate and severe hypoglycemia did not alter significantly resting cerebral blood flow and cerebrovascular resistance. In five other goats, L-NAME, administered during severe hypoglycemia, abolished the increase in cerebral blood flow, and increased cerebrovascular resistance and mean arterial pressure over the control (normoglycemic) values. In these animals with severe hypoglycemia, acetylcholine (0.01-1 microg), isoproterenol (0.03-3 microg) and diazoxide (0.3-9 mg), injected into the internal maxillary artery, decreased cerebrovascular resistance in a dose-dependent manner, and this decrease was similar before and after L-NAME. Therefore, insulin-induced hypoglycemia may produce cerebral vasodilatation by releasing nitric oxide and may diminish the capacity of the cerebral vasculature to release nitric oxide in response to acetylcholine.
本研究旨在探讨一氧化氮在低血糖对脑循环影响中的作用。用胰岛素诱导山羊发生低血糖,并在对照条件下以及给予一氧化氮合成抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME,47mg/kg)后,研究其对脑血流量(用置于上颌内动脉的电磁流量传感器测量)的影响。此外,还检测了在胰岛素诱导的严重低血糖期间、L-NAME治疗前后脑血管对血管舒张刺激的反应性。在五只处于对照条件下的动物中(血糖=90±7mg/dl,脑血流量=64±4ml/min,平均体动脉压=102±4mmHg,脑血管阻力=1.62±0.11mmHg/ml每分钟,心率=73±6次/分钟),胰岛素使血糖降低:当低血糖为中度(血糖=46±2mg/dl)或重度(血糖=26±1mg/dl)时,脑血流量分别增加25±4%和47±6%,脑血管阻力分别降低18±3%和34±4%。在基础条件下,L-NAME不影响血糖,但使静息脑血流量降低37±2%,使平均动脉压升高33±2%,使心率降低28±3%;给予L-NAME后,中度和重度低血糖均未显著改变静息脑血流量和脑血管阻力。在另外五只山羊中,在严重低血糖期间给予L-NAME,消除了脑血流量的增加,并使脑血管阻力和平均动脉压高于对照(正常血糖)值。在这些严重低血糖的动物中,向内颌动脉注射乙酰胆碱(0.01 - 1μg)、异丙肾上腺素(0.03 - 3μg)和二氮嗪(0.3 - 9mg),以剂量依赖的方式降低脑血管阻力,且这种降低在给予L-NAME前后相似。因此,胰岛素诱导的低血糖可能通过释放一氧化氮产生脑血管舒张,并可能降低脑血管对乙酰胆碱反应释放一氧化氮的能力。